B3GNT3 is associated with poor prognosis in NSCLC, particularly in lung adenocarcinoma, where it influences cell apoptosis and holds promise as an early cancer screening marker (52, 53). The gene discussed is B3GNT3; the disease is lung adenocarcinoma.